HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

p53, DCC and thymidylate synthase as predictors of survival after resection of hepatic metastases from colorectal cancer.

AbstractBACKGROUND:
Hepatic metastasis from colorectal cancer is a common problem. Hepatic resection offers the only chance of cure. Prognosis of patients following hepatic resection is currently based on clinicopathological factors (of both the primary cancer and the hepatic metastasis), which do not accurately predict the subsequent behaviour of the tumour. The aim of this study was to evaluate three molecular genetic markers - p53, DCC (deleted in colonic cancer) and thymidylate synthase - in both the primary colorectal tumour and the resected hepatic metastases, and to determine their correlation, if any, with survival in patients with resected hepatic metastases from colorectal cancer.
METHODS:
Sixty-three patients with hepatic metastases and 40 corresponding colorectal primary tumours were studied using immunohistochemical staining for p53, DCC and thymidylate synthase, as well as p53 gene mutations using polymerase chain reaction-single-stranded conformational polymorphism (PCR-SSCP) analysis. The results were correlated with survival.
RESULTS:
There was no correlation between p53, DCC or thymidylate synthase immunohistochemical staining, or between p53 PCR-SSCP analysis, and survival for either hepatic metastases or the colorectal primary tumour.
CONCLUSION:
Prediction of prognosis in patients having resection of hepatic metastases from colorectal cancer continues to be problematic. Other genetic markers or combination of markers need to be evaluated.
AuthorsR P M Saw, D Koorey, D Painter, P J Gallagher, M J Solomon
JournalThe British journal of surgery (Br J Surg) Vol. 89 Issue 11 Pg. 1409-15 (Nov 2002) ISSN: 0007-1323 [Print] England
PMID12390383 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers, Tumor
  • Genetic Markers
  • Thymidylate Synthase
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor
  • Colorectal Neoplasms
  • Female
  • Genes, p53
  • Genetic Markers
  • Humans
  • Immunohistochemistry (methods)
  • Liver Neoplasms (genetics, metabolism, secondary)
  • Male
  • Middle Aged
  • Mutation (genetics)
  • Polymerase Chain Reaction (methods)
  • Polymorphism, Single-Stranded Conformational
  • Prognosis
  • Survival Analysis
  • Thymidylate Synthase (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: